As of October 2024, Genexine has a market cap of $191.85M. This makes Genexine the world's 17605th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $266.85M | -13.74% |
2023 | $309.34M | -46.92% |
2022 | $582.75M | -68.01% |
2021 | $1.82B | -25.16% |
2018 | $2.43B | 6.71% |
2017 | $2.28B | 69.18% |
2016 | $1.35B | -8.09% |
2015 | $1.47B | 97.27% |
2014 | $743.67M | 75.00% |
2013 | $424.95M | 51.11% |
2012 | $281.22M | - |